Phase I Clinical Trial of PEG-IFN-SA in HCV Disease: Evidence for Drug Safety, Tolerance, and Antiviral Activity
Phase of Trial: Phase I/II
Latest Information Update: 04 Feb 2016
At a glance
- Drugs Interferon alfacon-1; Peginterferon alfa-2a; Peginterferon SA; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms PEG-IFN-SA
- 25 Jan 2016 Study design changed from double blind to open as per ClinicalTrials.gov record.
- 25 Jan 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 30 May 2012 New trial record